Show source-provided references
2. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
3. Japanese Gastric Cancer Association (2017). Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer, 20, 1–19.
10.1007/s10120-016-0622-4 ↗5. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer
10.1056/NEJMoa055531 ↗6. Thuss, P., Wolfgang, F., Jorg, T., Michael, K., Claudia, P., Thorsten Oliver, G., Elke, J., Johannes, M., Martin, H.S., and Ralf Hofheinz, S.-E.A.-B. (2017). Perioperative chemotherapy with docetaxel, oxaliplatin, and fluorouracil/leucovorin (FLOT) versus epirubicin, cisplatin, and fluorouracil or capecitabine (ECF/ECX) for resectable gastric or gastroesophageal junction (GEJ) adenocarcinoma (FLOT4-AIO): A multicenter, randomized phase 3 trial. J. Clin. Oncol.
7. Mismatch Repair Deficiency, Microsatellite Instability, and Survival: An Exploratory Analysis of the Medical Research Council Adjuvant Gastric Infusional Chemotherapy (MAGIC) Trial
10.1001/jamaoncol.2016.6762 ↗8. Petrillo, A., Pompella, L., Tirino, G., Pappalardo, A., Laterza, M.M., Caterino, M., Orditura, M., Ciardiello, F., Lieto, E., and Galizia, G. (2019). Perioperative Treatment in Resectable Gastric Cancer: Current Perspectives and Future Directions. Cancers, 11.
10.3390/cancers11030399 ↗9. Prognostic implication of molecular subtypes and response to neoadjuvant chemotherapy in 760 gastric carcinomas: Role of Epstein-Barr virus infection and high- and low-microsatellite instability
10.1002/cjp2.137 ↗10. Texture analysis as imaging biomarker of tumoral response to neoadjuvant chemoradiotherapy in rectal cancer patients studied with 3-T magnetic resonance
10.1097/RLI.0000000000000116 ↗13. Haralick’s texture features for the prediction of response to therapy in colorectal cancer: A preliminary study
10.1007/s11547-017-0833-8 ↗14. Caruso, D., Polici, M., Zerunian, M., Pucciarelli, F., Guido, G., Polidori, T., Landolfi, F., Nicolai, M., Lucertini, E., and Tarallo, M. (2021). Radiomics in Oncology, Part 1: Technical Principles and Gastrointestinal Application in CT and MRI. Cancers, 13.
10.3390/cancers13112522 ↗15. Caruso, D., Polici, M., Zerunian, M., Pucciarelli, F., Guido, G., Polidori, T., Landolfi, F., Nicolai, M., Lucertini, E., and Tarallo, M. (2021). Radiomics in Oncology, Part 2: Thoracic, Genito-Urinary, Breast, Neurological, Hematologic and Musculoskeletal Applications. Cancers, 13.
10.3390/cancers13112681 ↗16. Gastric cancer: Texture analysis from multidetector computed tomography as a potential preoperative prognostic biomarker
10.1007/s00330-016-4540-y ↗18. Pre-treatment MDCT-based texture analysis for therapy response prediction in gastric cancer: Comparison with tumour regression grade at final histology
10.1016/j.ejrad.2017.02.043 ↗19. Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy
10.1002/cncr.11660 ↗20. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging
10.3322/caac.21388 ↗21. (2021, March 28). AJCC—AJCC 8th Edition Cancer Staging Form, Histology and Topography Supplements Available Now. Available online: https://cancerstaging.org/About/news/Pages/AJCC-8th-Edition-Cancer-Staging-Form-and-Histology-and-Topography-Supplements-Available-Now.aspx.
22. Optimization of contrast medium volume for abdominal CT in oncologic patients: Prospective comparison between fixed and lean body weight-adapted dosing protocols
10.1186/s13244-021-00980-0 ↗23. Lean Body Weight-Tailored Iodinated Contrast Injection in Obese Patient: Boer versus James Formula
10.1155/2018/8521893 ↗24. Caruso, D., Zerunian, M., Pucciarelli, F., Bracci, B., Polici, M., D’Arrigo, B., Polidori, T., Guido, G., Barbato, L., and Polverari, D. (2021). Influence of Adaptive Statistical Iterative Reconstructions on CT Radiomic Features in Oncologic Patients. Diagnostics, 11.
10.3390/diagnostics11061000 ↗27. Histopathological regression of gastric adenocarcinoma after neoadjuvant therapy: A critical review
10.1111/apm.12642 ↗30. Sun, K.Y., Hu, H.T., Chen, S.L., Ye, J.N., Li, G.H., Chen, L.D., Peng, J.J., Feng, S.T., Yuan, Y.J., and Hou, X. (2020). CT-based radiomics scores predict response to neoadjuvant chemotherapy and survival in patients with gastric cancer. BMC Cancer, 20.
10.1186/s12885-020-06970-7 ↗31. Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI
10.1186/s13058-017-0846-1 ↗